Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2
NCT ID: NCT03320889
Last Updated: 2019-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
115 participants
INTERVENTIONAL
2017-10-30
2019-08-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1
NCT03245931
A Video-Based HCV Curriculum for Drug Users
NCT00241917
A Video-Based HCV Curriculum for Active Injection Drug Users
NCT00241943
Hepatitis C-Video vs. Brochure Education Delivery
NCT04204447
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
NCT00218192
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pamphlets plus Review with Expert Educator
Educational Intervention includes Pamphlets plus Review with Expert Educator
Educational Intervention
Patients will be randomized to a group that receives the pamphlets only and a group that receives the pamphlets and has an expert educator review that pamphlets with them and answer questions.
Pamphlets only
Educational Intervention includes Pamphlets only
Educational Intervention
Patients will be randomized to a group that receives the pamphlets only and a group that receives the pamphlets and has an expert educator review that pamphlets with them and answer questions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational Intervention
Patients will be randomized to a group that receives the pamphlets only and a group that receives the pamphlets and has an expert educator review that pamphlets with them and answer questions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The study will include patients with and without a Hepatitis C diagnosis.
* Patients will be recruited at their routine office visits and/or during any admissions to the hospital.
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TriHealth Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Marcotte, MD
Role: PRINCIPAL_INVESTIGATOR
TriHealth Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Good Samaritan Hospital
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-057
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.